281 related articles for article (PubMed ID: 21648138)
21. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review.
Röder E; Berger MY; de Groot H; van Wijk RG
Pediatr Allergy Immunol; 2008 May; 19(3):197-207. PubMed ID: 18221463
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of sublingual immunotherapy in children.
Bufe A
Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
[No Abstract] [Full Text] [Related]
23. [House dust mite allergy: myths and realities].
Bouton C; Ducommun J
Rev Med Suisse; 2009 Apr; 5(199):832-6. PubMed ID: 19441749
[TBL] [Abstract][Full Text] [Related]
24. Patient initiation and persistence with allergen immunotherapy.
Anolik R; Schwartz AM; Sajjan S; Allen-Ramey F
Ann Allergy Asthma Immunol; 2014 Jul; 113(1):101-7. PubMed ID: 24814759
[TBL] [Abstract][Full Text] [Related]
25. Long-term benefits of specific immunotherapy (SIT).
Olaguibel JM
Drugs Today (Barc); 2008 Dec; 44 Suppl B():39-41. PubMed ID: 19221617
[No Abstract] [Full Text] [Related]
26. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
27. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
Cochard MM; Eigenmann PA
J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
[No Abstract] [Full Text] [Related]
28. Safety of sublingual immunotherapy with a monomeric allergoid in very young children.
Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G
Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951
[No Abstract] [Full Text] [Related]
29. Sublingual immunotherapy for allergic rhinitis and conjunctivitis.
Passalacqua G; Garelli V; Sclifò F; Canonica GW
Immunotherapy; 2013 Mar; 5(3):257-64. PubMed ID: 23444955
[TBL] [Abstract][Full Text] [Related]
30. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Lin SY; Erekosima N; Kim JM; Ramanathan M; Suarez-Cuervo C; Chelladurai Y; Ward D; Segal JB
JAMA; 2013 Mar; 309(12):1278-88. PubMed ID: 23532243
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
Compalati E; Passalacqua G; Bonini M; Canonica GW
Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
[TBL] [Abstract][Full Text] [Related]
33. Sublingual immunotherapy.
Lin SY; Leatherman B
Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
[TBL] [Abstract][Full Text] [Related]
34. The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.
Adamic K; Zidarn M; Bajrovic N; Erzen R; Kopac P; Music E
Wien Klin Wochenschr; 2009; 121(9-10):357-60. PubMed ID: 19562302
[TBL] [Abstract][Full Text] [Related]
35. [Comparative study of the effectiveness of 2 methods of specific immunotherapy of pollinoses].
Polsacheva OV; Gushchin IS; Poroshina IuA; Chitaeva VG; Shustova VI
Ter Arkh; 1986; 58(4):120-3. PubMed ID: 2424113
[No Abstract] [Full Text] [Related]
36. Practice parameters for sublingual immunotherapy.
Ortolani C; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Ciprandi G; D'Anneo R; Di Gioacchino M; Di Rienzo V; Fiocchi A; Galimberti M; Galli E; Giovannini M; Incorvaia C; La Grutta S; Lombardi C; Marcucci F; Marseglia G; Minelli M; Musarra A; Nettis E; Novembre E; Pajno G; Patriarca G; Pezzuto F; Piras P; Pucci S; Romano A; Romano C; Quercia O; Scala G; Schiavino D; Senna G; Sforza G; Tosca M; Tripodi S; Frati F
Monaldi Arch Chest Dis; 2006 Mar; 65(1):44-6. PubMed ID: 16700194
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
39. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy evaluation of specific immunotherapy with standardized dermatophagoides pteronyssinus extract for allergic rhinitis accompanied with asthma].
Chen J; Kong W; Xiang J; Shu H; Shi Q; Tan H; Lu Z; Zhou Y; Zhang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jan; 24(2):57-9. PubMed ID: 20306851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
